A carregar...

Characterization of Resistance to the Protease Inhibitor GS-9451 in Hepatitis C Virus-Infected Patients

GS-9451, a novel hepatitis C virus (HCV) nonstructural 3/4a (NS3/4a) protease inhibitor, is highly active in patients infected with HCV genotype 1 (GT 1). The aim of this study is to characterize the clinical resistance profile of GS-9451 in GT 1 HCV-infected patients in a phase 1, 3-day monotherapy...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Dvory-Sobol, Hadas, Wong, Kelly A., Ku, Karin S., Bae, Andrew, Lawitz, Eric J., Pang, Phillip S., Harris, Jeanette, Miller, Michael D., Mo, Hongmei
Formato: Artigo
Idioma:Inglês
Publicado em: American Society for Microbiology 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3457362/
https://ncbi.nlm.nih.gov/pubmed/22869562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00780-12
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!